Search results
Author(s):
Moritake Iguchi
,
Hiromichi Wada
,
Felipe Martínez
,
et al
Added:
1 year ago
Author(s):
Maki Komiyama
,
Moritake Iguchi
,
Hiromichi Wada
,
et al
Added:
10 months ago
Author(s):
Andrew JS Coats
Added:
5 months ago
AHA Conference 2024 - Discover the findings from a new study on the impact of diastolic dysfunction on the efficacy of empagliflozin in heart failure in the EMPEROR-Preserved trial.Prof Andrew Coats (Heart Research Institute, New South Wales, AU) joins us onsite at AHA Conference to discuss findings from a new analysis of diastolic dysfunction in the EMPEROR-Preserved trial (NCT03057951).EMPEROR…
View more
Author(s):
Byoung Geol Choi
,
Seung-Woon Rha
,
Se Yeon Choi
,
et al
Added:
9 months ago
Author(s):
Frederick Raal
Added:
1 year ago
ESC 23 — Prof Frederick Raal (University of the Witwatersrand, Johannesburg, SA) outlines the late-breaking results from the LIBerte-HeFH study (NCT04797104).
The phase III LIBerte-HeFH study (LIB Therapeutics LLC) aimed to assess the effectiveness of PCSK9-inhibitor Ierodalcibep (LIB003) in reducing low-density lipoprotein cholesterol (LDL-C) in 300mg doses administered subcutaneously in…
View more
Author(s):
Maria Lorenza Muiesan
Added:
2 months ago
Author(s):
Filippo Gurgoglione
,
Giampaolo Niccoli
Added:
6 months ago
Author(s):
Massimiliano Camilli
,
Luca Maggio
,
Lorenzo Tinti
,
et al
Added:
2 months ago
David Wheeler
Research Area(s) / Expertise:
Job title: Professor of Kidney Medicine
Author